wellness and medical devices services for the quantitative measurement of body composition, an integral part of the new healthcare paradigm based on prevention. Here, Dr. Sung-Ho Han, its CEO and founder together with Andrew Son, chief strategy officer, sheds light on the first two years of the company, the upcoming launch of the abdominal fat scanner, Bello, and his future ambitions to conquer the US market.

(The rest was omitted)

Original article: https://pharmaboardroom.com/interviews/sung-ho-han-ceo-andrew-son-chief-strategy-officer-olive-healthcare-south-korea/